Miralles Gines Diego 4
4 · NeuBase Therapeutics, Inc. · Filed Jul 16, 2019
Insider Transaction Report
Form 4
Miralles Gines Diego
Director
Transactions
- Award
Stock option (right to buy)
2019-07-12+227,330→ 227,330 totalExercise: $5.39Exp: 2029-07-12→ Common stock (227,330 underlying)
Footnotes (1)
- [F1]1/36th of the total shares subject to the option shall vest monthly over three years.